CSIMarket
 


Celgene Corp  (CELG)
Other Ticker:  
 

Cumulative Celgene's Quick Ratio for Trailing Twelve Months Period

CELG's Quick Ratio for Trailing Twelve Months Period and Cash & cash equivalent, Current Liabilities growth


Select the Comparisons : Select the Ratio:

CELG Quick Ratio for Trailing Twelve Months Period

(Sep 30 2019)
III. Quarter
(Jun 30 2019)
II. Quarter
(Mar 31 2019)
I. Quarter
(Dec 31 2018)
IV. Quarter
(Sep 30 2018)
III. Quarter
Y / Y Current Liabilities Growth 36 % -18.15 % 26.97 % 35.82 % -9.04 %
Y / Y Cash & cash equivalent Growth 152.39 % 161.48 % 50.41 % -60.72 % -63.33 %
Quick Ratio for Trailing Twelve Months Period 1.88 1.61 1.2 1.11 1.7
Total Ranking # 1063 # 1211 # 1512 # 1605 # 1147
Seq. Current Liabilities Growth 35.93 % -6.83 % -2.51 % 10.15 % -18.19 %
Seq. Cash & cash equivalent Growth 24.95 % 23.95 % 48.56 % 9.69 % 29.45 %


Quick Ratio for Trailing Twelve Months Period Comment for 12 Months ending at Sep 30 2019
On the trailing twelve months basis Celgene Corp Cash & cash equivalent average more than doubled by 152.39% in III. Quarter year on year, faster than Current Liabilities, this led to increase in in Celgene's Quick Ratio for Trailing Twelve Months Period to 1.88, Quick Ratio for Trailing Twelve Months Period remained below Celgene Corp average.
Quick Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies operatig within Major Pharmaceutical Preparations industry 283 other companies have achieved higher Quick Ratio for Trailing Twelve Months Period than Celgene. While overall ranking remained unchanged compare to previous quarter at no. .

What is Quick Ratio?
Learn more about CELG
Quick Ratio CELG in the most recent quarter
Quick Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 284
Sector # 461
S&P 500 # 927


Quick Ratio for Trailing Twelve Months Period Statistics
High Average Low
7.91 3.67 1.11
(March 31, 2007)   (Dec 31 2018)




Companies with similar average Quick Ratio for Trailing Twelve Months Period for 12 months ending Sep 30 2019, within Major Pharmaceutical Preparations Industry Quick Ratio for Trailing Twelve Months Period
Guardion Health Sciences Inc   5.15 
Travere Therapeutics Inc   5.15 
Clementia Pharmaceuticals Inc.  5.05 
Mersana Therapeutics Inc   5.00 
Tetraphase Pharmaceuticals Inc  4.97 
Cyclacel Pharmaceuticals Inc   4.96 
Syndax Pharmaceuticals Inc   4.91 
Bioxcel Therapeutics Inc   4.91 
Verastem inc   4.90 
Oncosec Medical Incorporated  4.89 
Scynexis Inc   4.87 
Clovis Oncology inc   4.87 
Phio Pharmaceuticals Corp   4.84 
Merrimack Pharmaceuticals Inc  4.84 
Ampio Pharmaceuticals inc   4.83 
Portola Pharmaceuticals inc   4.78 
Urovant Sciences Ltd   4.77 
Stemline Therapeutics Inc  4.75 
Xoma Corporation  4.72 
Theriva Biologics inc   4.71 
Tyme Technologies Inc.  4.69 
Cytomx Therapeutics Inc   4.65 
Salarius Pharmaceuticals inc   4.64 
Ovid Therapeutics Inc   4.63 
Abeona Therapeutics Inc   4.63 
Esperion Therapeutics inc   4.61 
Dynavax Technologies Corporation  4.60 
Pacira Biosciences inc   4.52 
Chiasma Inc   4.49 
Cormedix Inc   4.47 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com